User profiles for Alessandro Aiuti
 | Alessandro AiutiTIGET; Istituto Scientifico San Raffaele; Università Vita Salute San Raffaele Verified email at hsr.it Cited by 29336 |
Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning
Hematopoietic stem cell (HSC) gene therapy for adenosine deaminase (ADA)–deficient
severe combined immunodeficiency (SCID) has shown limited clinical efficacy because of the …
severe combined immunodeficiency (SCID) has shown limited clinical efficacy because of the …
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
INTRODUCTION Interindividual clinical variability is vast in humans infected with severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), ranging from silent infection to rapid …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), ranging from silent infection to rapid …
Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy
…, F Ciceri, A Rovelli, MG Roncarolo, A Aiuti… - Science, 2013 - science.org
Introduction Metachromatic leukodystrophy (MLD) is a neurodegenerative lysosomal
storage disease caused by arylsulfatase A (ARSA) deficiency. The disease primarily affects …
storage disease caused by arylsulfatase A (ARSA) deficiency. The disease primarily affects …
X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19
Autosomal inborn errors of type I IFN immunity and autoantibodies against these cytokines
underlie at least 10% of critical COVID-19 pneumonia cases. We report very rare, …
underlie at least 10% of critical COVID-19 pneumonia cases. We report very rare, …
Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency
…, F Ciceri, MG Roncarolo, A Aiuti - Blood, The Journal …, 2016 - ashpublications.org
Adenosine deaminase (ADA) deficiency is a rare, autosomal-recessive systemic metabolic
disease characterized by severe combined immunodeficiency (SCID). The treatment of …
disease characterized by severe combined immunodeficiency (SCID). The treatment of …
A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1)
Chemotactic factors are postulated to direct emigration of lymphocytes from the blood stream
into sites of inflammation. Members of a family of chemotactic cytokines, termed chemokines…
into sites of inflammation. Members of a family of chemotactic cytokines, termed chemokines…
The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ …
A Aiuti, IJ Webb, C Bleul, T Springer… - The Journal of …, 1997 - rupress.org
Hematopoietic progenitor cells migrate in vitro and in vivo towards a gradient of the chemotactic
factor stromal cell-derived factor-1 (SDF-1) produced by stromal cells. This is the first …
factor stromal cell-derived factor-1 (SDF-1) produced by stromal cells. This is the first …
Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome
A Aiuti, L Biasco, S Scaramuzza, F Ferrua, MP Cicalese… - Science, 2013 - science.org
Introduction Wiskott-Aldrich syndrome (WAS) is a primary immunodeficiency characterized
by eczema, thrombocytopenia, infections, and a high risk of developing autoimmunity and …
by eczema, thrombocytopenia, infections, and a high risk of developing autoimmunity and …
[HTML][HTML] Gene therapy for immunodeficiency due to adenosine deaminase deficiency
A Aiuti, F Cattaneo, S Galimberti… - … England Journal of …, 2009 - Mass Medical Soc
Background We investigated the long-term outcome of gene therapy for severe combined
immunodeficiency (SCID) due to the lack of adenosine deaminase (ADA), a fatal disorder of …
immunodeficiency (SCID) due to the lack of adenosine deaminase (ADA), a fatal disorder of …
[HTML][HTML] Coronavirus disease 2019 in patients with inborn errors of immunity: an international study
…, VG Sankaran, YY Demirdag, V Lougaris, A Aiuti… - Journal of Allergy and …, 2021 - Elsevier
Background There is uncertainty about the impact of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection in individuals with rare inborn errors of immunity (IEI), a …
coronavirus 2 (SARS-CoV-2) infection in individuals with rare inborn errors of immunity (IEI), a …
